These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 21036697

  • 21. Antitumor efficacy of bcl-2 and c-myc antisense oligonucleotides in combination with cisplatin in human melanoma xenografts: relevance of the administration sequence.
    Zupi G, Scarsella M, Semple SC, Mottolese M, Natali PG, Leonetti C.
    Clin Cancer Res; 2005 Mar 01; 11(5):1990-8. PubMed ID: 15756025
    [Abstract] [Full Text] [Related]

  • 22. Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice.
    Zhang X, Zhang J, Wang L, Wei H, Tian Z.
    BMC Cancer; 2007 Aug 04; 7():149. PubMed ID: 17683579
    [Abstract] [Full Text] [Related]

  • 23. Oblimersen sodium (G3139 Bcl-2 antisense oligonucleotide) therapy in Waldenstrom's macroglobulinemia: a targeted approach to enhance apoptosis.
    Frankel SR.
    Semin Oncol; 2003 Apr 04; 30(2):300-4. PubMed ID: 12720157
    [Abstract] [Full Text] [Related]

  • 24. Bcl-2 inhibitors potentiate the cytotoxic effects of radiation in Bcl-2 overexpressing radioresistant tumor cells.
    Hara T, Omura-Minamisawa M, Chao C, Nakagami Y, Ito M, Inoue T.
    Int J Radiat Oncol Biol Phys; 2005 Feb 01; 61(2):517-28. PubMed ID: 15667975
    [Abstract] [Full Text] [Related]

  • 25. CpG immunomer DNA enhances antisense protein kinase A RIalpha inhibition of multidrug-resistant colon carcinoma growth in nude mice: molecular basis for combinatorial therapy.
    Nesterova MV, Johnson NR, Stewart T, Abrams S, Cho-Chung YS.
    Clin Cancer Res; 2005 Aug 15; 11(16):5950-5. PubMed ID: 16115938
    [Abstract] [Full Text] [Related]

  • 26. Knock-down of Bcl-2 by antisense oligodeoxynucleotides induces radiosensitization and inhibition of angiogenesis in human PC-3 prostate tumor xenografts.
    Anai S, Goodison S, Shiverick K, Hirao Y, Brown BD, Rosser CJ.
    Mol Cancer Ther; 2007 Jan 15; 6(1):101-11. PubMed ID: 17237270
    [Abstract] [Full Text] [Related]

  • 27. Bcl-2 antisense oligonucleotide overcomes resistance to E1A gene therapy in a low HER2-expressing ovarian cancer xenograft model.
    Bartholomeusz C, Itamochi H, Yuan LX, Esteva FJ, Wood CG, Terakawa N, Hung MC, Ueno NT.
    Cancer Res; 2005 Sep 15; 65(18):8406-13. PubMed ID: 16166319
    [Abstract] [Full Text] [Related]

  • 28. c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice.
    Citro G, D'Agnano I, Leonetti C, Perini R, Bucci B, Zon G, Calabretta B, Zupi G.
    Cancer Res; 1998 Jan 15; 58(2):283-9. PubMed ID: 9443406
    [Abstract] [Full Text] [Related]

  • 29. Bcl-XL antisense oligonucleotides coupled with antennapedia enhances radiation-induced apoptosis in pancreatic cancer.
    Masui T, Hosotani R, Ito D, Kami K, Koizumi M, Mori T, Toyoda E, Nakajima S, Miyamoto Y, Fujimoto K, Doi R.
    Surgery; 2006 Aug 15; 140(2):149-60. PubMed ID: 16904964
    [Abstract] [Full Text] [Related]

  • 30. Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo.
    Hu Y, Cherton-Horvat G, Dragowska V, Baird S, Korneluk RG, Durkin JP, Mayer LD, LaCasse EC.
    Clin Cancer Res; 2003 Jul 15; 9(7):2826-36. PubMed ID: 12855663
    [Abstract] [Full Text] [Related]

  • 31. Oblimersen in the treatment of metastatic melanoma.
    Tarhini AA, Kirkwood JM.
    Future Oncol; 2007 Jun 15; 3(3):263-71. PubMed ID: 17547520
    [Abstract] [Full Text] [Related]

  • 32. The combination of the proteasome inhibitor bortezomib and the bcl-2 antisense molecule oblimersen sensitizes human B-cell lymphomas to cyclophosphamide.
    O'Connor OA, Smith EA, Toner LE, Teruya-Feldstein J, Frankel S, Rolfe M, Wei X, Liu S, Marcucci G, Chan KK, Chanan-Khan A.
    Clin Cancer Res; 2006 May 01; 12(9):2902-11. PubMed ID: 16675587
    [Abstract] [Full Text] [Related]

  • 33. [The inhibitory effect of bcl-2 antisense oligodeoxynucleotide/RNA on the growth of cervical carcinoma in vitro].
    Mi R, Wang H, Qu Q.
    Zhonghua Fu Chan Ke Za Zhi; 2000 Feb 01; 35(2):105-8. PubMed ID: 11809111
    [Abstract] [Full Text] [Related]

  • 34. [Combinational effects of bcl-2 antisense oligodeoxynucleotide and Rituximab on proliferation and apoptosis of B-lymphoma Raji cells].
    Shen YM, Yang XC, Shi YZ, Xie XF, Tang J.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Aug 01; 23(8):727-30. PubMed ID: 17618565
    [Abstract] [Full Text] [Related]

  • 35. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer.
    Robinson LA, Smith LJ, Fontaine MP, Kay HD, Mountjoy CP, Pirruccello SJ.
    Ann Thorac Surg; 1995 Dec 01; 60(6):1583-91. PubMed ID: 8787447
    [Abstract] [Full Text] [Related]

  • 36. [Inhibitory effect of bcl-2 antisense oligodeoxynucleotides on growth of human lung carcinoma xenograft in nude mice].
    He DM, Zhang H.
    Ai Zheng; 2006 Jan 01; 25(1):40-4. PubMed ID: 16405747
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of Stat3 activation and tumor growth suppression of non-small cell lung cancer by G-quartet oligonucleotides.
    Weerasinghe P, Garcia GE, Zhu Q, Yuan P, Feng L, Mao L, Jing N.
    Int J Oncol; 2007 Jul 01; 31(1):129-36. PubMed ID: 17549413
    [Abstract] [Full Text] [Related]

  • 38. [bcl-2 expression in small cell lung cancer: a mechanism for apoptosis antagonism and immune evasion].
    Zheng JM, Wang DK, Jiang HM.
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Dec 01; 25(12):1537-9. PubMed ID: 16361157
    [Abstract] [Full Text] [Related]

  • 39. Enhanced radiosensitivity by inhibition of the anti-apoptotic gene clusterin using antisense oligodeoxynucleotide in a human bladder cancer model.
    Yamanaka K, Gleave M, Muramaki M, Hara I, Miyake H.
    Oncol Rep; 2005 May 01; 13(5):885-90. PubMed ID: 15809754
    [Abstract] [Full Text] [Related]

  • 40. Chemosensitization of breast carcinoma cells with the use of bcl-2 antisense oligodeoxynucleotide.
    Yang JH, Feng F, Qian H, Cheng H.
    Breast; 2004 Jun 01; 13(3):227-31. PubMed ID: 15177426
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.